CN112679328A - Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-ketone - Google Patents

Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-ketone Download PDF

Info

Publication number
CN112679328A
CN112679328A CN201910987122.7A CN201910987122A CN112679328A CN 112679328 A CN112679328 A CN 112679328A CN 201910987122 A CN201910987122 A CN 201910987122A CN 112679328 A CN112679328 A CN 112679328A
Authority
CN
China
Prior art keywords
reaction
cyclohexene
ketone
trifluoromethyl
iodine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910987122.7A
Other languages
Chinese (zh)
Other versions
CN112679328B (en
Inventor
辛茂树
张树强
陈志华
朱经伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmablock Sciences (nanjing) Inc
Original Assignee
Pharmablock Sciences (nanjing) Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmablock Sciences (nanjing) Inc filed Critical Pharmablock Sciences (nanjing) Inc
Priority to CN201910987122.7A priority Critical patent/CN112679328B/en
Publication of CN112679328A publication Critical patent/CN112679328A/en
Application granted granted Critical
Publication of CN112679328B publication Critical patent/CN112679328B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to an industrial production method of 3-trifluoromethyl-2-cyclohexene-1-ketone, which is prepared by iodination and trifluoromethylation of 1, 3-cyclohexanedione, the yield is obviously improved compared with the prior art, special reaction conditions such as high temperature and high pressure are not needed, heavy metal pollution reagents are not used, the reaction and post-treatment are simple, the product is easy to purify, and the method is suitable for industrial production.

Description

Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-ketone
Technical Field
The invention relates to the field of synthesis of medical intermediates, in particular to an industrial production method of 3-trifluoromethyl-2-cyclohexene-1-ketone.
Background
Fluorine atoms are often applied to the structural optimization of compounds due to strong electronegativity and small atomic radius, so that the physicochemical properties of the compounds, the drug effects, toxicity, metabolic processes and the like of drug molecules are improved, trifluoromethylated products occupy a large proportion in the fluorine atoms, and the introduction of trifluoromethyl can possibly improve the polarity, dipole moment, stability and lipophilicity of target products. 3-trifluoromethyl-2-cyclohexene-1-ketone as a medical intermediate can be used for preparing 3- (trifluoromethyl) cyclohexyl-1-alcohol, 3- (trifluoromethyl) phenol and the like so as to further synthesize various clinical candidate compounds or drug molecules.
There are two main methods for preparing 3-trifluoromethyl-2-cyclohexene-1-one reported in the prior literature.
Route 1(Journal of Fluorine Chemistry,101 (2); 199. sup. -; 202; 2000)
Figure BDA0002237044200000011
In the route 1, 2-cyclohexene-1-ketone is used as an initial raw material, and a target compound is obtained through trifluoromethylation and rearrangement. In the third step, the reaction conversion is incomplete, and the yield is only 28%; and pyridinium chlorochromate (PCC, containing heavy metal chromium) is used, chromium is a heavy metal with high toxicity, easily enters human cells, damages internal organs and DNA such as liver and kidney, accumulates in human body, has carcinogenicity, possibly induces gene mutation, and also causes serious pollution to the environment, so that the amplification use of the chromium is limited, and the chromium can only be used for synthesis at laboratory level.
Route 2(Tetrahedron Letters, (42), 4071-2; 1979)
Figure BDA0002237044200000012
Route 2 uses 3-bromo-2-cyclohexene-1-one as raw material, copper powder, hexamethylphosphoramide and trifluoroiodomethane are synthesized into CuCF3Then synthesizing a target compound with 3-bromo-2-cyclohexene-1-ketone; CuCF3The method is unstable, needs to be prepared at present, is gas trifluoroiodomethane, needs to be carried out under the conditions of sealing and high temperature of 120 ℃, has high requirements on reaction equipment, has certain safety risk, is not suitable for amplification operation, and has the yield of 40%.
Therefore, the development of an industrial production method of 3-trifluoromethyl-2-cyclohexene-1-ketone with safety, environmental protection, low equipment requirement and good yield is still needed.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides the preparation method of the 3-trifluoromethyl-2-cyclohexene-1-ketone, which has the advantages of easily obtained raw materials of the reagent, safety, environmental protection, no need of special reaction conditions such as high temperature and high pressure, no use of heavy metal pollution reagents, simple reaction and post-treatment, easy purification of the product, higher yield than the route reported by the literature, and suitability for industrial production.
The preparation method of the 3-trifluoromethyl-2-cyclohexene-1-ketone comprises the following steps:
the method comprises the following steps: 1, 3-cyclohexanedione is used as a starting material,
Figure BDA0002237044200000021
preparing 3-iodine-2-cyclohexene-1-ketone by iodination;
Figure BDA0002237044200000022
step two: 3-iodine-2-cyclohexene-1-ketone reacts under the condition of a fluorination reagent to prepare 3-trifluoromethyl-2-cyclohexene-1-ketone, wherein the fluorination reagent is fluorosulfonyl difluoroacetic acid methyl ester, fluorosulfonyl difluoroacetic acid ethyl ester or trimethylsilyl 2- (fluorosulfonyl) difluoroacetic acid ester
Figure BDA0002237044200000023
Preferably, the reaction solvent in step one is toluene.
The inventor unexpectedly finds that in the solvent screening of the first step, compared with acetonitrile generally used in the reaction of the type in the prior art, toluene is used as a reaction solvent, so that the post-reaction treatment operation is simple, the operation of column chromatography can be avoided, the impurity content of the product in the first step can be remarkably reduced, and the method is more suitable for industrial production. Other materials such as dichloromethane and tetrahydrofuran have good solubility, but have low boiling points, so that the reaction is slow; n-heptane has poor solubility for raw materials, auxiliary materials and products; the temperature rise is very obvious in the process of feeding DMF as a solvent, and the temperature is not easy to control in the operation process.
Preferably, the reaction system of the iodination reaction in the step one is elementary iodine/triphenylphosphine/triethylamine or N-iodosuccinimide/triphenylphosphine/triethylamine.
Preferably, the reaction temperature in step one is 70-85 ℃.
Preferably, the fluorinating agent in the second step is methyl fluorosulfonyl difluoroacetate.
Preferably, the reaction solvent in the second step is N, N-dimethylformamide, and the catalyst is cuprous iodide or cupric iodide.
Preferably, the first step further comprises post-treatment, wherein the post-treatment is specifically quenching and washing after the reaction is finished, adding toluene for azeotropy after the solvent is dried by rotation, adding methyl tert-butyl ether into the residue, stirring and filtering, adding anhydrous magnesium chloride into the obtained filtrate for complexation, filtering again, and evaporating the obtained filtrate to dryness to obtain the 3-iodo-2-cyclohexen-1-one.
The preparation method provided by the invention has the advantages that the total yield of two steps is about 50%, compared with the prior art, the preparation method is obviously improved, special reaction conditions such as high temperature and high pressure are not required, the use of heavy metal pollution reagents is not involved, the reaction and post-treatment are simple, the product is easy to purify, and the preparation method is suitable for industrial production.
Detailed Description
EXAMPLE 13 preparation of iodo-2-cyclohexen-1-one
Toluene (16kg) was added to a double glass kettle (50L), triphenylphosphine (5.0kg,19.0mol,1.1eq.) was added with stirring, iodine solid (5.0kg,19.2mol,1.1eq.) was added in portions at 5-10 deg.C, stirring was carried out for 20min, and triethylamine (1.9kg,19.0mol,1.1eq.) was added. Then 1, 3-cyclohexanedione (1.8kg,16.5mol,1.0eq.) was added at 5-10 ℃ and after addition the temperature was slowly raised to 75-80 ℃ and maintained at this temperature for 16h of reaction.
And (3) post-treatment: adding saturated sodium bisulfite aqueous solution (10L) into the system after cooling, stirring for 10 minutes for liquid separation, removing solvent by organic phase under reduced pressure and azeotropically removing water by toluene (100kg), adding methyl tert-butyl ether (10L) after cooling to dryness, stirring for 1 hour, filtering, washing filter cake with methyl tert-butyl ether (5L), mixing filtrates, transferring into a kettle, adding anhydrous magnesium chloride (1.2kg), complexing for 2 hours, filtering, washing filter cake with methyl tert-butyl ether (10L), mixing filtrates, concentrating to dryness to obtain light yellow liquid (2.6kg), and purifying>98%。1HNMR(400MHz):6.81~6.82(s,1H),2.90~2.94(m,2H),2.42~2.45(m,2H),2.07~2.00)m,2H);GCMS:222.9。
EXAMPLE 23 preparation of trifluoromethyl-2-cyclohexen-1-one
Adding DMF (16kg) into a double-layer glass kettle (50L), and adding 3-iodo-2-cyclohexen-1-one (3.0kg,11.7mol,1.00eq.) and cuprous iodide (0.4kg, 2.3mol, 0.02eq.) with stirring; methyl fluorosulfonyl difluoroacetate (2.8kg,14.7mol,1.25eq.) was added in one portion, and the mixture was heated to 75-80 ℃ for reaction for 12 h. After the reaction is finished, the temperature is reduced to 20-25 ℃, methyl tert-butyl ether (10L multiplied by 3) is extracted for three times, and the organic phase is concentrated, desolventized and rectified to obtain 3-trifluoromethyl-2-cyclohexene-1-ketone (1.35kg) with the purity of 99%.1HNMR(400MHz):6.38-6.39(m,1H),2.49-2.52(m,4H),2.11-2.18(m,2H);
19FNMR(400MHz):71.15;GCMS:165.1。
EXAMPLE 3 preparation of 3-iodo-2-cyclohexen-1-one post-treatment screening
Referring to the preparation method of example 1, the reaction solvent was toluene or acetonitrile, and the post-treatment mode was selected, and the operation and results are shown in table 1.
TABLE 1
Figure BDA0002237044200000041

Claims (10)

1. A preparation method of 3-trifluoromethyl-2-cyclohexene-1-ketone is characterized by comprising the following steps:
the method comprises the following steps: 1, 3-cyclohexanedione is used as a starting material,
Figure FDA0002237044190000011
preparing 3-iodine-2-cyclohexene-1-ketone by iodination;
Figure FDA0002237044190000012
step two: 3-iodine-2-cyclohexene-1-ketone reacts under the condition of a fluorination reagent to prepare 3-trifluoromethyl-2-cyclohexene-1-ketone, wherein the fluorination reagent is fluorosulfonyl difluoroacetic acid methyl ester, fluorosulfonyl difluoroacetic acid ethyl ester or trimethylsilyl 2- (fluorosulfonyl) difluoroacetic acid ester
Figure FDA0002237044190000013
2. The method of claim 1, wherein: the reaction solvent in the first step is toluene.
3. The method of claim 1, wherein: in the first step, the reaction system of the iodination reaction is elementary iodine/triphenylphosphine/triethylamine or N-iodosuccinimide/triphenylphosphine/triethylamine.
4. The method of claim 1, wherein: the reaction temperature in the first step is 70-85 ℃.
5. The method of claim 1, wherein: the fluorinating reagent in the second step is methyl fluorosulfonyl difluoroacetate.
6. The method of claim 1, wherein: and the reaction solvent in the second step is N, N-dimethylformamide, and the catalyst is cuprous iodide or copper iodide.
7. The method of claim 1, wherein: the first step also comprises post-treatment.
8. The preparation method according to claim 7, wherein the post-treatment is specifically quenching and washing after the reaction is finished, adding toluene for azeotropy after the solvent is dried by rotation, adding methyl tert-butyl ether to the residue, stirring and filtering, adding anhydrous magnesium chloride to the obtained filtrate for complexing, filtering again, and evaporating the obtained filtrate to dryness to obtain the 3-iodo-2-cyclohexen-1-one.
9. The method according to claim 8, wherein the purity of the 3-iodo-2-cyclohexen-1-one obtained in step one is greater than or equal to 98%.
10. The method according to claim 1, characterized by comprising the steps of:
the method comprises the following steps: 1, 3-cyclohexanedione is used as a starting material,
Figure FDA0002237044190000014
taking methylbenzene as a reaction solvent, and carrying out iodination reaction in a reaction system of elementary iodine/triphenylphosphine/triethylamine or N-iodosuccinimide/triphenylphosphine/triethylamine, wherein the reaction temperature is 70-85 ℃; quenching and washing after the reaction is finished, adding toluene for azeotropy after the solvent is dried, adding methyl tert-butyl ether into the residue, stirring and filtering, adding anhydrous magnesium chloride into the obtained filtrate for complexing, filtering again, evaporating the obtained filtrate to dryness to obtain 3-iodine-2-cyclohexene-1-one;
Figure FDA0002237044190000021
step two: 3-iodine-2-cyclohexene-1-ketone reacts under the condition of fluorosulfonyl difluoroacetic acid methyl ester to prepare 3-trifluoromethyl-2-cyclohexene-1-ketone, DMF is used as a reaction solvent, and cuprous iodide or copper iodide is used as a catalyst
Figure FDA0002237044190000022
CN201910987122.7A 2019-10-17 2019-10-17 Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-one Active CN112679328B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910987122.7A CN112679328B (en) 2019-10-17 2019-10-17 Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-one

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910987122.7A CN112679328B (en) 2019-10-17 2019-10-17 Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-one

Publications (2)

Publication Number Publication Date
CN112679328A true CN112679328A (en) 2021-04-20
CN112679328B CN112679328B (en) 2023-09-15

Family

ID=75444610

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910987122.7A Active CN112679328B (en) 2019-10-17 2019-10-17 Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-one

Country Status (1)

Country Link
CN (1) CN112679328B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201827406A (en) * 2016-12-27 2018-08-01 美商百健Ma公司 Nrf2 activator
US20190047947A1 (en) * 2017-08-14 2019-02-14 Allergan, Inc. 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof
CN109438327A (en) * 2018-12-28 2019-03-08 巢湖学院 A kind of fused ring compound and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201827406A (en) * 2016-12-27 2018-08-01 美商百健Ma公司 Nrf2 activator
US20190047947A1 (en) * 2017-08-14 2019-02-14 Allergan, Inc. 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof
CN109438327A (en) * 2018-12-28 2019-03-08 巢湖学院 A kind of fused ring compound and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FAIYAZ KHAN 等: "Palladium-Catalyzed Ullmann Cross-Coupling of β-Iodoenones and β-Iodoacrylates with o-Halonitroarenes or o-Iodobenzonitriles and Reductive Cyclization of the Resulting Products To Give Diverse Heterocyclic Systems" *
YOSHIRO KOBAYASHI 等: "TRIFLUOROMETHYLATION OF ALIPHATIC HALIDES WITH TRIFLUOROMETHYL COPPER" *

Also Published As

Publication number Publication date
CN112679328B (en) 2023-09-15

Similar Documents

Publication Publication Date Title
WO2020147861A1 (en) Electrochemical preparation method for β-trifluoromethylamide compound
US11820724B2 (en) Method for preparing 2-ethyl-4-fluoro-1-nitrobenzene
JP2018523662A (en) Novel process for producing chromanone derivatives
JP2002193887A (en) Method for producing iodonium salt compound
CN107540655B (en) Novel method for preparing S- (perfluoroalkyl) -dibenzothiophene trifluoromethanesulfonate
CN117304094A (en) Synthesis method of 3-trifluoromethyl pyridine or 3-difluoro methyl pyridine compound
JP3480825B2 (en) Purification method of 1,1,1,5,5,5-hexafluoroacetylacetone
CN112679328B (en) Industrial production method of 3-trifluoromethyl-2-cyclohexene-1-one
KR101894091B1 (en) New method for preparation of chromanone derivatives
JP6963435B2 (en) Method for producing intermediate of biotin and method for producing biotin
JP3806962B2 (en) Method for producing 3,5-bis (trifluoromethyl) bromobenzene
JP7420550B2 (en) Method for producing 2-hydroxy-2-(perfluoroalkyl) malonic acid ester derivative, and 2-(trimethylsilyloxy)-2-(perfluoroalkyl) malonic acid ester derivative and 5-hydroxy-5-(perfluoroalkyl) Pyrimidine-2,4,6(1H,3H,5H)-trione and their production method
US6894197B2 (en) Process for producing fluorinated alcohol
CN109081826B (en) Preparation method of oxidant IBX
CN115626861B (en) Method for synthesizing trifluoromethyl aromatic compound
JP2008174552A (en) Method for producing 4-perfluoroisopropylanilines
JP5000031B2 (en) Method for producing aromatic-o-dialdehyde compound
JP3899626B2 (en) Preparation of 2-mercaptothiazol
CN116813508A (en) Method for synthesizing 5-halogeno-2-methylbenzoic acid with high selectivity
CN106748605B (en) Method for synthesizing o-dicarbonyl aryl formate series compounds based on TBAB and Oxone methods
CN107417543B (en) Method for synthesizing bromo-fused ring aromatic compound
CN114591225A (en) Method for large-scale production of 2, 6-dibromo-4-methylpyridine
CN117486788A (en) Preparation method of 2-chloro-3-bromo-6-methylpyridine
CN113461615A (en) Preparation method of 4-fluoro-1H-pyrazole
CN111825581A (en) Method for synthesizing trifluoromethylthio compound by using trifluoromethylsulfinyl chloride

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant